Lymphoma Patients who Remain Event-Free Two Years after Diagnosis have a Normal Life Expectancy

Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years after diagnosis have essentially the same life expectancy as they did prior to diagnosis, a Mayo Clinic study has found. Cancer related outcome events include disease progression or relapse, need for re-treatment or death.